Dietary antioxidants and prostate cancer: A review

Nutrition and Cancer

Volumn 65, Issue 6, 2013, Pages 793-801

  Vance, Terrence M ^a   Su, Joseph ^b   Fontham, Elizabeth T H ^c   Koo, Sung I ^a   Chun, Ock K ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CAROTENOID; GAMMA TOCOPHEROL; LYCOPENE; POLYPHENOL; PROSTATE SPECIFIC ANTIGEN; SELENIUM;

ADVANCED CANCER; CANCER INCIDENCE; CANCER RISK; COFFEE; DIET SUPPLEMENTATION; DIETARY INTAKE; HUMAN; MEN'S HEALTH; NUTRITIONAL ASSESSMENT; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW (TOPIC); TEA;

EID: 84882408722     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.806672     Document Type: Review

References (76)

1. Siegel R, Ward E, Brawley O, and Jemal A: Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61, 212-236, 2011.
2. Patel AR and Klein EA: Risk factors for prostate cancer. Nat Clin Pract Urol 6(2), 87-95, 2009.
3. Dunn MW and Kazer MW: Prostate cancer overview. Semin Oncol Nurs 27, 241-250, 2011.
4. Nelson WG, DeMarzo AM, and Isaacs WB: Prostate cancer.NEngl J Med 349, 366-381, 2003.
5. Hori S, Butler E, and McLoughlin J: Prostate cancer and diet: Food for thought? BJU Int 107, 1348-1359, 2011.
6. Zhang L, et al.: Prostate cancer: An emerging threat to the health of aging men in Asia. Asian J Androl 13, 574-578, 2011.
7. Gronberg H: Prostate cancer epidemiology. Lancet 361(9360), 859-864, 2003.
8. Kheirandish P and Chinegwundoh F: Ethnic differences in prostate cancer. Br J Cancer 105, 481-485, 2011.
9. WillisMSandWians FH: The role of nutrition in preventing prostate cancer: A review of the proposed mechanism of action of various dietary substances. Clin Chim Acta 330, 57-83, 2003.
10. Blot WJ, et al.: Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 85, 1483-1492, 1993.
11. Klein EA, et al.: Vitamin E and the risk of prostate cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 306, 1549-1556, 2011.
12. Lonn E, et al.: Effects of long-term vitamin E supplementation on cardiovascular events and cancer: A randomized controlled trial. JAMA 293, 1338-1347, 2005.
13. Gaziano JM, et al.: Vitamins E and C in the prevention of prostate and total cancer in men: The Physicians' Health Study II randomized controlled trial. JAMA 301, 52-62, 2009.
14. Heinonen OP, et al.: Prostate cancer and supplementation with alphatocopherol and beta-carotene: Incidence and mortality in a controlled trial. J Natl Cancer Inst 90, 440-446, 1998.
15. Hartman TJ, et al.: The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev 7, 335-340, 1998.
16. Weinstein SJ, et al.: Serum and dietary vitamin E in relation to prostate cancer risk. Cancer Epidemiol Biomarkers Prev 16, 1253-1259, 2007.
17. Rodriguez C, et al.: Vitamin E supplements and risk of prostate cancer in U.S. men. Cancer Epidemiol Biomarkers Prev 13, 378-382.2004.
18. Schuurman AG, Goldbohm RA, Brants HA, and van den Brandt PA: A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands). Cancer Causes Control 13, 573-582, 2002.
19. Virtamo J, et al.: Incidence of cancer and mortality following alphatocopherol and beta-carotene supplementation: A postintervention followup. JAMA 290, 476-485, 2003.
20. Wright ME, et al.: Supplemental and dietary vitamin E intakes and risk of prostate cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 16, 1128-1135, 2007.
21. Kirsh VA, et al.: Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst 98, 245-254, 2006.
22. Vlajinac HD, Marinkovic JM, Ilic MD, and Kocev NI: Diet and prostate cancer: A case-control study. Eur J Cancer 33(1), 101-107, 1997.
23. Deneo-Pellegrini H, De Stefani E, Ronco A, and Mendilaharsu M: Foods, nutrients and prostate cancer: A case-control study in Uruguay. Br J Cancer 80, 591-597, 1999.
24. Bidoli E, et al.: Dietary vitamins E and C and prostate cancer risk. Acta Oncol 48, 890-894, 2009.
25. Hodge AM, et al.: Foods, nutrients and prostate cancer. Cancer Causes Control 15, 11-20, 2004.
26. McCann SE, et al.: Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer 53, 33-41, 2005.
27. National Research Council. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. National Academy of Sciences, Institute of Medicine. Food and Nutrition Board, 2000.
28. Jiang Q, Wong J, Fyrst H, Saba JD, and Ames BN: Gamma-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis. Proc Natl Acad Sci USA 101, 17825-17830, 2004.
29. Huang Y, et al.: A gamma-tocopherol-rich mixture of tocopherols maintains Nrf2 expression in prostate tumors of TRAMP mice via epigenetic inhibition of CpG methylation. J Nutr 142, 818-823, 2012.
30. Ledesma MC, et al.: Selenium and vitamin E for prostate cancer: Post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status. Mol Med 17(1-2), 134-143, 2011.
31. Schrauzer GN: Selenium and cancer: A review. Bioinorg Chem 5, 275-281, 1976.
32. Duffield-Lillico AJ, et al.: Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: An analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int 91, 608-612, 2003.
33. Marshall JR, et al.: Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila) 4, 1761-1769, 2011.
34. Algotar A M, et al.: Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer. Prostate 73, 328-335, 2013.
35. West DW, SlatteryML, Robison LM, French TK, and Mahoney AW: Adult dietary intake and prostate cancer risk in Utah: A case-control study with special emphasis on aggressive tumors. Cancer Causes Control 2(2), 85-94, 1991.
36. Clark LC, et al.: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276, 1957-1963, 1996.
37. Clark LC, et al.: Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial. Br J Urol 81, 730-734, 1998.
38. Peters U and Takata Y: Selenium and the prevention of prostate and colorectal cancer. Mol Nutr Food Res 52, 1261-1272, 2008.
39. Block G: Vitamin C and cancer prevention: The epidemiologic evidence. Am J Clin Nutr 53(1 Suppl), 270S-282S, 1991.
40. Omenn, G S, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 88, 1550-1559, 1996.
41. Ohno Y, et al.: Dietary beta-carotene and cancer of the prostate: A casecontrol study in Kyoto, Japan. Cancer Res 48, 1331-1336, 1988.
42. Mettlin C, Selenskas S, Natarajan N, and Huben R: Beta-carotene and animal fats and their relationship to prostate cancer risk. A case-control study. Cancer 64, 605-612, 1989.
43. Hsing AW, et al.: Diet, tobacco use, and fatal prostate cancer: Results from the Lutheran Brotherhood Cohort Study. Cancer Res 50, 6836-6840, 1990.
44. Norrish AE, Jackson RT, Sharpe SJ, and Skeaff CM: Prostate cancer and dietary carotenoids. Am J Epidemiol 151, 119-123, 2000.
45. Ghadirian P, et al.: Nutritional factors and prostate cancer: A case-control study of French Canadians inMontreal, Canada. Cancer Causes Control 7, 428-436, 1996.
46. Kirsh VA, et al.: A prospective study of lycopene and tomato product intake and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15, 92-98, 2006.
47. Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, andWillett WC:Aprospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 94, 391-398, 2002.
48. Kucuk O, et al.: Effects of lycopene supplementation in patients with localized prostate cancer. Exp Biol Med (Maywood) 227, 881-885, 2002.
49. Bunker CH, et al.: A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk. Nutr Cancer 57, 130-137, 2007.
50. van Breemen RB, et al.: Antioxidant effects of lycopene in African American men with prostate cancer or benign prostate hyperplasia: A randomized, controlled trial. Cancer Prev Res (Phila) 4, 711-718, 2011.
51. Bettuzzi S, et al.: Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-ofprinciple study. Cancer Res 66, 1234-1240, 2006.
52. Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, and Tsugane S: Green tea consumption and prostate cancer risk in Japanese men: A prospective study. Am J Epidemiol 167, 71-77, 2008.
53. Jian L, Xie LP, Lee AH, andBinns CW: Protective effect of green tea against prostate cancer: A case-control study in southeast China. Int J Cancer 108, 130-135, 2004.
54. Brausi M, Rizzi F, and Bettuzzi S: Chemoprevention of human prostate cancer by green tea catechins: Two years later. A follow-up update. Eur Urol 54, 472-473, 2008.
55. Jain MG, Hislop GT, Howe GR, Burch JD, and Ghadirian P: Alcohol and other beverage use and prostate cancer risk among Canadian men. Int J Cancer 78, 707-711. 1998.
56. Slattery ML and West DW: Smoking, alcohol, coffee, tea, caffeine, and theobromine: Risk of prostate cancer in Utah (United States). Cancer Causes Control 4, 559-563, 1993.
57. Sonoda T, et al.: A case-control study of diet and prostate cancer in Japan: Possible protective effect of traditional Japanese diet. Cancer Sci 95, 238-242, 2004.
58. Severson RK, Nomura AM, Grove JS, and Stemmermann GN: A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49, 1857-1860, 1989.
59. Kikuchi N, et al.: No association between green tea and prostate cancer risk in Japanese men: The Ohsaki Cohort Study. Br J Cancer 95, 371-373, 2006.
60. Allen NE, et al.: A prospective study of diet and prostate cancer in Japanese men. Cancer Causes Control 15, 911-920, 2004.
61. Bosetti C, et al.: Flavonoids and prostate cancer risk: A study in Italy. Nutr Cancer 56, 123-127, 2006.
62. Wilson KM, et al.: Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. J Natl Cancer Inst 103, 876-884, 2011.
63. Shafique K, et al.: Coffee consumption and prostate cancer risk: Further evidence for inverse relationship. Nutr J 11, 42, 2012.
64. Arab L, et al.: Coffee consumption and prostate cancer aggressiveness among African and Caucasian Americans in a population-based study. Nutr Cancer 2012.
65. Meyer F, et al.: Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial. Int J Cancer 116, 182-186, 2005.
66. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 360(9326), 23-33, 2002.
67. Fleshner NE, et al.: Progression from high-grade prostatic intraepithelial neoplasia to cancer: A randomized trial of combination vitamin-E, soy, and selenium. J Clin Oncol 29, 2386-2390, 2011.
68. Jiang L, et al.: Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: A meta-analysis of randomized controlled trials. Nutr Cancer 62, 719-727, 2010.
69. Akinloye O, Adaramoye O, and Kareem O: Changes in antioxidant status and lipid peroxidation in Nigerian patients with prostate carcinoma. Pol Arch Med Wewn 119, 526-532, 2009.
70. Arsova-Sarafinovska Z, et al.: Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer. Clin Biochem 42, 1228-1235, 2009.
71. Aydin A, et al.: Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia. Clin Biochem 39, 176-179, 2006.
72. Zhang J, Dhakal IB, Lang NP, and Kadlubar FF: Polymorphisms in inflammatory genes, plasma antioxidants, and prostate cancer risk. Cancer Causes Control 21, 1437-1444, 2010.
73. Zhang J, Dhakal IB, Greene G, Lang NP, and Kadlubar FF: Polymorphisms in hOGG1 and XRCC1 and risk of prostate cancer: Effects modified by plasma antioxidants. Urology 75, 779-785, 2010.
74. Li H, et al.:Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res 65, 2498-2504. 2005.
75. Goodman M, et al.: Lycopene intake and prostate cancer risk: Effect modification by plasma antioxidants and the XRCC1 genotype. Nutr Cancer 55, 13-20, 2006.
76. Narayanan B A, Narayanan NK, Stoner GD, and Bullock BP. Interactive gene expression pattern in prostate cancer cells exposed to phenolic antioxidants. Life Sci 70, 1821-1839, 2002.